Influential factors | Complications developed (% or 95% CI) | P value | |
---|---|---|---|
Yes | No | ||
Gender | |||
Female | 2 (40) | 3 (60) | 1 |
Male | 115 (31.4) | 251 (68.6) | |
Age (years) | 38.97 (37.29–40.64) | 37.51 (36.26–38.76) | 0.096 |
Malaria parasite type of patient infection | |||
Plasmodium falciparum | 109 (34.2) | 210 (65.8) | 0.034 |
Plasmodium ovale | 7 (20.6) | 27 (79.4) | |
Plasmodium vivax | 1 (7.7) | 12 (92.3) | |
Plasmodium malariae | 0 (0) | 5 (100) | |
Rank of healthcare facilities for the initial diagnosis | |||
Provincial healthcare institutions | 25 (20.8) | 95 (79.2) | < 0.001 |
Municipal healthcare institutions | 23 (31.1) | 51 (68.9) | |
County healthcare institutions | 16 (27.1) | 43 (72.9) | |
Township health centre | 8 (47.1) | 9 (52.9) | |
Village clinic | 10 (21.7) | 36 (78.3) | |
Private clinic | 35 (63.6) | 20 (36.4) | |
Initial diagnosis | |||
Misdiagnosis | 84 (44.4) | 105 (55.6) | < 0.001 |
Correct diagnosis | 33 (18.1) | 149 (81.9) | |
Time interval between onset and initial diagnosis | 1.62 (1.02–2.21) | 4.24 (1.90–6.59) | 0.052 |
Time interval between initial diagnosis and final diagnosis | 5.16 (4.08–6.25) | 3.17 (2.66–3.69) | < 0.001 |
Time interval between onset and final diagnosis | 6.78 (5.57–7.99) | 7.42 (5.05–9.78) | 0.002 |
Time interval between onset and drug therapy | 5.69 (4.60–6.79) | 6.53 (4.16–8.90) | 0.001 |
Days of taking medicine | 7.71 (7.16–8.25) | 6.26 (5.97–6.54) | < 0.001 |